SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000930413-20-001199
Filing Date
2020-04-24
Accepted
2020-04-24 16:08:20
Documents
6
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 c95145_defa14a.htm DEFA14A 35766
2 GRAPHIC x4_c95145x1x1.jpg GRAPHIC 2525
3 GRAPHIC x4_c95145x1x2.jpg GRAPHIC 4191
4 GRAPHIC x4_c95145x2x1.jpg GRAPHIC 2865
5 GRAPHIC x4_c95145x3x1.jpg GRAPHIC 2852
6 GRAPHIC x4_c95145x4x1.jpg GRAPHIC 2801
  Complete submission text file 0000930413-20-001199.txt   58589
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19034 | Film No.: 20815022
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences